|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US6093699A
(en)
|
1987-07-09 |
2000-07-25 |
The University Of Manitoba |
Method for gene therapy involving suppression of an immune response
|
|
ATE157012T1
(de)
|
1989-11-03 |
1997-09-15 |
Univ Vanderbilt |
Verfahren zur in vivo-verabreichung von funktionsfähigen fremden genen
|
|
US5279833A
(en)
|
1990-04-04 |
1994-01-18 |
Yale University |
Liposomal transfection of nucleic acids into animal cells
|
|
WO1991018088A1
(en)
|
1990-05-23 |
1991-11-28 |
The United States Of America, Represented By The Secretary, United States Department Of Commerce |
Adeno-associated virus (aav)-based eucaryotic vectors
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
CA2096222C
(en)
|
1990-11-13 |
1998-12-29 |
Stephen D. Lupton |
Bifunctional selectable fusion genes
|
|
US5587308A
(en)
|
1992-06-02 |
1996-12-24 |
The United States Of America As Represented By The Department Of Health & Human Services |
Modified adeno-associated virus vector capable of expression from a novel promoter
|
|
EP0646178A1
(en)
|
1992-06-04 |
1995-04-05 |
The Regents Of The University Of California |
expression cassette with regularoty regions functional in the mammmlian host
|
|
WO1994017810A1
(en)
|
1993-02-12 |
1994-08-18 |
The Wistar Institute Of Anatomy And Biology |
Recombinant cytomegalovirus vaccine
|
|
WO1994023744A1
(en)
|
1993-04-16 |
1994-10-27 |
The Wistar Institute Of Anatomy And Biology |
Recombinant cytomegalovirus vaccine
|
|
CN1127527A
(zh)
|
1993-05-17 |
1996-07-24 |
加利福尼亚大学董事会 |
人免疫缺陷型病毒感染和艾滋病的核酶基因治疗方法
|
|
WO1994028143A1
(en)
|
1993-05-21 |
1994-12-08 |
Targeted Genetics Corporation |
Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
|
|
US5998205A
(en)
|
1994-11-28 |
1999-12-07 |
Genetic Therapy, Inc. |
Vectors for tissue-specific replication
|
|
WO1996026742A1
(en)
|
1995-02-28 |
1996-09-06 |
The Regents Of The University Of California |
Gene transfer-mediated angiogenesis therapy
|
|
US6001650A
(en)
|
1995-08-03 |
1999-12-14 |
Avigen, Inc. |
High-efficiency wild-type-free AAV helper functions
|
|
EP1983057A3
(en)
|
1995-09-08 |
2009-01-07 |
Genzyme Corporation |
Improved AAV vectors for gene therapy
|
|
US6004797A
(en)
|
1995-11-09 |
1999-12-21 |
Avigen, Inc. |
Adenovirus helper-free recombinant AAV Virion production
|
|
FR2743818B1
(fr)
*
|
1996-01-23 |
1998-04-10 |
Agronomique Inst Nat Rech |
Constructions d'adn et vecteurs d'expression derives du gene de l'arn va i d'adenovirus
|
|
US6228646B1
(en)
|
1996-03-07 |
2001-05-08 |
The Regents Of The University Of California |
Helper-free, totally defective adenovirus for gene therapy
|
|
EP0912873B1
(de)
|
1996-07-16 |
2000-12-06 |
STEYR MANNLICHER Aktiengesellschaft & Co. KG |
Gewehr mit lösbarer laufbefestigung
|
|
JPH1033175A
(ja)
|
1996-07-24 |
1998-02-10 |
Hisamitsu Pharmaceut Co Inc |
組換えアデノ随伴ウイルスベクターの製造方法
|
|
IL128736A0
(en)
|
1996-09-06 |
2000-01-31 |
Univ Pennsylvania |
Methods using cre-lox for production of recombinant adeno-associated viruses
|
|
DE19650714A1
(de)
|
1996-12-06 |
1998-06-10 |
Melchner Harald Von Prof Dr |
Genfallen-Konstrukt zur Identifizierung und Isolierung von Genen
|
|
US6743620B1
(en)
|
1996-12-16 |
2004-06-01 |
Eisai Co., Ltd. |
Method for preparing retrovirus vector for gene therapy
|
|
CA2269661A1
(en)
|
1996-12-18 |
1998-06-25 |
Targeted Genetics Corporation |
Recombinase-activatable aav packaging cassettes for use in the production of aav vectors
|
|
US6303302B1
(en)
|
1997-11-19 |
2001-10-16 |
The Whitehead Institute For Biomedical Research |
Regulation of fungal gene expression
|
|
AU3097399A
(en)
|
1998-03-20 |
1999-10-11 |
Trustees Of The University Of Pennsylvania, The |
Compositions and methods for helper-free production of recombinant adeno-associated viruses
|
|
US6291214B1
(en)
|
1998-05-11 |
2001-09-18 |
Glaxo Wellcome Inc. |
System for generating recombinant viruses
|
|
KR20020057975A
(ko)
|
1999-10-29 |
2002-07-12 |
오미야 히사시 |
유전자 도입 방법
|
|
DE19955558C2
(de)
|
1999-11-18 |
2003-03-20 |
Stefan Kochanek |
Permanente Amniozyten-Zelllinie, ihre Herstellung und Verwendung zur Herstellung von Gentransfervektoren
|
|
EP1134287A1
(en)
|
2000-03-08 |
2001-09-19 |
Universite De Geneve |
A system to control the expression of a given gene using another gene that encodes a polypeptide with recombinant activity
|
|
AU2001257611A1
(en)
|
2000-04-28 |
2001-11-12 |
Avigen, Inc. |
Polynucleotides for use in recombinant adeno-associated virus virion production
|
|
CA2416701A1
(en)
|
2000-07-21 |
2002-01-31 |
The United States Of America, As Represented By The Secretary Of Agricul Ture |
Methods for the replacement, translocation and stacking of dna in eukaryotic genomes
|
|
US6593123B1
(en)
|
2000-08-07 |
2003-07-15 |
Avigen, Inc. |
Large-scale recombinant adeno-associated virus (rAAV) production and purification
|
|
AU2002219841A1
(en)
|
2000-11-16 |
2002-05-27 |
Cornell Research Foundation Inc. |
Vectors for conditional gene inactivation
|
|
US7074611B2
(en)
|
2001-04-27 |
2006-07-11 |
Gie-Cerbn, Centre Europeen De Recherche En Biologie Et En Medecine (Gie) |
Method for the stable inversion of DNA sequence by site-specific recombination and DNA vectors and transgenic cells thereof
|
|
DE10210139A1
(de)
|
2002-03-07 |
2003-10-23 |
Medigene Ag |
Helferkonstrukte für die Herstellung hybrider rAAV-Partikel unterschiedlicher AAV-Serotypen
|
|
WO2003084977A1
(en)
|
2002-04-04 |
2003-10-16 |
Xiao Xiao |
Gene expression control system and its use in recombinant virus packaging cell lines
|
|
US7267979B2
(en)
|
2002-07-01 |
2007-09-11 |
Pioneer Hi-Bred International, Inc. |
Method of controlling gene silencing using site specific recombination
|
|
EP1546397A4
(en)
|
2002-09-27 |
2007-10-31 |
Cold Spring Harbor Lab |
CELL BASED RNA INTERFERENCE AND ASSOCIATED METHODS AND COMPOSITIONS
|
|
FR2852021B1
(fr)
*
|
2003-03-04 |
2007-12-07 |
|
Methodes et outils pour le criblage d'arn actifs in cellulo
|
|
DE602004030327D1
(de)
|
2003-05-21 |
2011-01-13 |
Genzyme Corp |
Verfahren zur herstellung von präparationen rekombinanter aav-virionen, die weitgehend frei von leeren capsiden sind
|
|
US20050130919A1
(en)
|
2003-07-18 |
2005-06-16 |
University Of Massachusetts |
Regulatable promoters for synthesis of small hairpin RNA
|
|
EP1512742A1
(en)
|
2003-09-08 |
2005-03-09 |
Margarete Odenthal |
Conditional modification of sirnas expression
|
|
WO2005116225A1
(en)
|
2004-05-25 |
2005-12-08 |
Children's Hospital Medical Center |
Method for introducing and expressing rna in cells
|
|
DE602004002471T2
(de)
|
2004-06-22 |
2007-01-18 |
Alcatel |
Verfahren und System zur Beteitstellung einer Übertragungsverbindung für Datenstromverkehr
|
|
US20060110390A1
(en)
|
2004-08-25 |
2006-05-25 |
Myogen, Inc. |
Inhibition of Ku as a treatment for cardiovascular diseases
|
|
US7189561B2
(en)
|
2004-09-21 |
2007-03-13 |
Advec, Inc. |
Production of adenovirus vectors with reduced levels of replication competent adenovirus contamination
|
|
DE102005054628A1
(de)
|
2005-11-16 |
2007-05-24 |
Cevec Pharmaceuticals Gmbh |
Verfahren zur Herstellung von permanenten humanen Zelllinien
|
|
AU2006339519A1
(en)
|
2005-12-16 |
2007-09-13 |
The Uab Research Foundation |
Compositions and methods related to controlled gene expression using viral vectors
|
|
US20100173387A1
(en)
|
2006-04-28 |
2010-07-08 |
Universitat Autonoma De Barcelona |
Method for producing adenovirus vectors for gene therapy and dna sequences used therefor
|
|
RS56844B1
(sr)
|
2007-12-11 |
2018-04-30 |
Univ North Carolina Chapel Hill |
Retrovirusni vektori sa modifikovanim polipurinskim nizom
|
|
IL201999A
(en)
|
2009-11-08 |
2017-10-31 |
Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel |
A knockout mouse of the 1 – mo gene, a gene associated with morbidly extreme obesity
|
|
DK2529020T3
(en)
|
2010-01-28 |
2018-08-06 |
Childrens Hospital Philadelphia |
SCALABLE PREPARATION PLATF FOR CLEANING VIRAL VECTORS AND CLEANED VIRAL VECTORS FOR USE IN GENTHERAPY
|
|
US20130058871A1
(en)
|
2011-07-28 |
2013-03-07 |
Howard Hughes Medical Institute |
Method and system for mapping synaptic connectivity using light microscopy
|
|
ES2857773T5
(es)
|
2011-08-24 |
2024-06-04 |
Univ Leland Stanford Junior |
Nuevas proteínas de la cápside de AAV para la transferencia de ácidos nucleicos
|
|
AU2013249202B2
(en)
|
2012-04-18 |
2018-08-09 |
The Children's Hospital Of Philadelphia |
Composition and methods for highly efficient gene transfer using AAV capsid variants
|
|
CN104540382A
(zh)
|
2012-06-12 |
2015-04-22 |
弗·哈夫曼-拉罗切有限公司 |
用于产生条件性敲除等位基因的方法和组合物
|
|
DK2931897T3
(en)
|
2012-12-12 |
2018-02-05 |
Broad Inst Inc |
CONSTRUCTION, MODIFICATION AND OPTIMIZATION OF SYSTEMS, PROCEDURES AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND THERAPEUTICAL APPLICATIONS
|
|
US10183978B2
(en)
|
2013-01-27 |
2019-01-22 |
Exemplar Genetics, Llc |
Animal models of duchenne muscular dystrophy
|
|
KR20240090694A
(ko)
|
2013-07-22 |
2024-06-21 |
더 칠드런스 호스피탈 오브 필라델피아 |
변종 ａａｖ 및 조성물, 세포, 기관 및 조직으로의 유전자 전이를 위한 방법 및 용도
|
|
EP3039129B1
(en)
|
2013-08-30 |
2018-06-27 |
Amgen Inc. |
High titer recombinant aav vector production in adherent and suspension cells
|
|
WO2016057800A1
(en)
|
2014-10-09 |
2016-04-14 |
The Regents Of The University Of California |
Targeted disruption of a csf1-dap12 pathway member gene for the treatment of neuropathic pain
|
|
KR102243243B1
(ko)
|
2014-10-23 |
2021-04-22 |
리제너론 파마슈티칼스 인코포레이티드 |
신규한 cho 통합 부위 및 이의 용도
|
|
AU2016362317B2
(en)
|
2015-12-01 |
2023-03-16 |
Spark Therapeutics, Inc. |
Scalable methods for producing recombinant Adeno-Associated Viral (AAV) vector in serum-free suspension cell culture system suitable for clinical use
|
|
WO2017189683A1
(en)
|
2016-04-26 |
2017-11-02 |
Massachusetts Institute Of Technology |
Extensible recombinase cascades
|
|
WO2018096356A1
(en)
|
2016-11-28 |
2018-05-31 |
Horizon Discovery Limited |
Methods for conditional gene knock-out
|
|
WO2018150271A1
(en)
*
|
2017-02-17 |
2018-08-23 |
Lonza Ltd. |
Mammalian cells for producing adeno-associated viruses
|
|
AU2018281306B2
(en)
|
2017-06-07 |
2025-04-17 |
Spark Therapeutics, Inc. |
Enhancing agents for improved cell transfection and/or rAAV vector production
|
|
US20200332278A1
(en)
|
2017-06-16 |
2020-10-22 |
Universite De Strasbourg |
Methods to generate conditional knock-in models
|
|
MY207534A
(en)
|
2017-06-30 |
2025-03-03 |
Spark Therapeutics Inc |
Aav vector column purification methods
|
|
EP3456822A1
(en)
|
2017-09-19 |
2019-03-20 |
CEVEC Pharmaceuticals GmbH |
Inducible aav rep genes
|
|
IL275462B2
(en)
|
2017-12-22 |
2026-01-01 |
Genentech Inc |
Targeted integration of nucleic acids
|
|
WO2019217483A1
(en)
*
|
2018-05-07 |
2019-11-14 |
Spark Therapeutics, Inc. |
Plasmid free aav vector producing cell lines
|
|
GB201816919D0
(en)
|
2018-10-17 |
2018-11-28 |
Glaxosmithkline Ip Dev Ltd |
Adeno-associated viral vector producer cell lines
|
|
SG11202106217TA
(en)
*
|
2018-12-21 |
2021-07-29 |
Lonza Walkersville Inc |
Adeno-associated virus (aav) producer cell line and related methods
|